Funder
National Key Clinical Specialty Discipline Construction Program of China
National Natural Science Foundation of China
Natural Science Foundation of Beijing Municipality
Subject
Pharmacology,General Medicine
Reference132 articles.
1. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial;Brose;Lancet,2014
2. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;New Engl. J. Med,2007
3. Sorafenib in advanced hepatocellular carcinoma;Llovet;New Engl. J. Med,2008
4. Sorafenib modulates the LPS- and Aβ-induced neuroinflammatory response in cells, wild-type mice, and 5xFAD mice;Kim;Front Immunol.,2021
5. Identification of sorafenib as a treatment for type 1 diabetes;Zeng;Front Immunol.,2022
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献